These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 520078)

  • 1. Cephalexin therapy for infections complicated by age and concurrent diseases. A study in general practice.
    Cooke DM
    Chemotherapy; 1979; 25(6):356-61. PubMed ID: 520078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephalexin in lower respiratory tract infections.
    Raff MJ
    Postgrad Med J; 1983; 59 Suppl 5():32-9. PubMed ID: 6364088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cephalexin: clinical effectiveness in geriatric patients.
    Smith IM
    Geriatrics; 1977 Mar; 32(3):91-5, 99. PubMed ID: 844692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalexin in the treatment of upper respiratory tract infections.
    Disney FA
    Postgrad Med J; 1983; 59 Suppl 5():28-31. PubMed ID: 6364087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cepharadine and cephalexin in the treatment of respiratory and urinary tract infections.
    Mogabgab WJ
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):421-32. PubMed ID: 4284
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of twice daily cephalexin.
    Browning AK
    Pharmatherapeutica; 1981; 2(9):559-64. PubMed ID: 7267673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Saito K; Ubukata K; Konno M
    Jpn J Antibiot; 1977 Sep; 30(9):672-6. PubMed ID: 916187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and laboratory studies on S-6437 (a new longacting granule of cephalexin) in pediatric field (author's transl)].
    Kondo K; Kuno K; Koide T; Fukaya K; Jose H
    Jpn J Antibiot; 1977 Sep; 30(9):691-8. PubMed ID: 916190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of S-6436 in adult patients with acute upper respiratory tract infections (author's transl)].
    Osawa T; Kawai T; Tabakotani F; Tsuda T; Hamazaki Y; Maeda H
    Jpn J Antibiot; 1978 Jan; 31(1):27-47. PubMed ID: 344928
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial in patients with infectious diseases of a new injectable cephalosporin derivative: lysine salt of cephalexin].
    Restivo O; Caruso R
    Arch Maragliano Patol Clin; 1976; 32():37-45. PubMed ID: 1053292
    [No Abstract]   [Full Text] [Related]  

  • 11. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
    Silvia G; Giambrone F; Battaglia E; Romano M
    G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of S-6437, sustained release cephalexin, in pediatrics (author's transl)].
    Sato H; Fujii N; Shinnou K; Kojima S; Hirama Y
    Jpn J Antibiot; 1977 Sep; 30(9):684-90. PubMed ID: 916189
    [No Abstract]   [Full Text] [Related]  

  • 13. Cephalexin dosage in general practice assessed by double-blind trial.
    Johnson SE; Foord RD
    Curr Med Res Opin; 1972; 1(1):37-48. PubMed ID: 4589401
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of the preparation Palitrex (cephalexin monohydrate)].
    Wojtacha-Wencel B; Urbańska D; Wojnar J
    Wiad Lek; 1982 Jun; 35(6):385-90. PubMed ID: 7123926
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cephalexin in internal medicine. Antibacterial treatment in 30 patients, 10 of them with malignant hemopathies, including 6 cases of agranulocytosis (granulocytes 1500/mm3)].
    Mizon JP; Gentit F
    Lille Med; 1975 Jan; 20(1):58-60. PubMed ID: 124374
    [No Abstract]   [Full Text] [Related]  

  • 16. Cephalexin in lower respiratory infections.
    Practitioner; 1972 Mar; 208(245):421-3. PubMed ID: 4554484
    [No Abstract]   [Full Text] [Related]  

  • 17. Cephalexin therapy for infections in the elderly and other vulnerable patients.
    Cooke DM; Browning AK
    Curr Med Res Opin; 1980; 7(1):62-7. PubMed ID: 7428416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical administration of cephalexin pival-oxy-methyl ester in bronchopneumonic diseases].
    Ghiringhelli G
    Bronchopneumologie; 1979; 29(4):346-53. PubMed ID: 509336
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cephalexin in daily practice. A multi-center study of Swiss pediatricians and ENT-specialists (author's transl)].
    Hagmann R
    Schweiz Rundsch Med Prax; 1978 Oct; 67(40):1471-7. PubMed ID: 704538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.